Palvella Therapeutics, Inc. (PVLA) Dividend History

Palvella Therapeutics, Inc. is a biopharmaceutical company focused on developing therapies for dermatological and other dermatology-related diseases. It specializes in innovative topical treatments aimed at addressing unmet medical needs in skin-related conditions.

Dividend History

Palvella Therapeutics, Inc. currently does not pay dividends

Company News

  • Ebenbuild Contributes Cutting-Edge Digital Lung Simulations to Pulmonary Fibrosis Drug Development

    Ebenbuild's digital twin technology Twinhale was used in a study published in Nature Communications, demonstrating the potential of inhaled therapeutics for treating idiopathic pulmonary fibrosis (IPF). The simulations revealed how the novel inhaled Anticalin® protein PRS-220 can effectively target diseased lung tissue, paving the way for more efficient therapies for IPF patients.

    GlobeNewswire Inc.
Page data last updated 08/19/2025 16:49:16 UTC